In a significant move to enhance Korea’s presence in the biotechnology market, the Korea Trade-Investment Promotion Agency (KOTRA) and SK Biopharmaceuticals have signed a memorandum of understanding to create a collaboration framework in the U.S. This partnership aims to support Korean biotech firms in expanding internationally as K-bio exports surged to a record $16.4 billion in 2025. KOTRA and SK will provide resources like office space, operational expertise, and tailored consulting to help navigate regulatory challenges and foster local partnerships in the U.S.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.koreatimes.co.kr/business/companies/20260608/kotra-sk-biopharmaceuticals-join-forces-to-back-k-bio-expansion-in-us
